Results 1 to 10 of about 89 (82)

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course [PDF]

open access: yesActa Biomedica Scientifica, 2019
Background. The use of atypical antipsychotics in schizophrenia contributes to the reduction of psychotic, affective, negative and cognitive disorders.Aims.
L. A. Ivanova   +4 more
doaj   +3 more sources

Risk management of metabolic disorders in the use of antipsychotics [PDF]

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
Cardio-metabolic risk factors and diabetes mellitus type 2 are highly prevalent in patients with schizophrenia. Decrease of metabolic risks associated with use of atypical antipsychotics is connected with the development of specialised programs. They can
G. E. Mazo, A. O. Kibitov
doaj   +2 more sources

Replacement of antipsychotics as a method of preventing the formation of resistance in schizophrenia [PDF]

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
The article is devoted to the methods of overcoming therapeutic resistance in patients with schizophrenia, in particular, during the replacement of antipsychotic therapy.
G. E. Mazo, L. N. Gorobets
doaj   +2 more sources

Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction [PDF]

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
The article presents compelling evidence of the need to draw attention of physicians to the problem of neyroleptical hyperprolactinemia. The article provides information about different prolactogen activity of antipsychotics with the release of the ...
L. N. Gorobets, G. E. Mazo
doaj   +2 more sources

Влияние луразидона на когнитивное функционирование больных шизофренией: система= тический обзор доказательных исследований препарата

open access: yesСовременная терапия психических расстройств, 2021
В статье выполнен краткий обзор современных представлений о месте когнитивных нарушений в структуре шизофренического процесса, а также о роли атипичных антипсихотиков в вопросе их коррекции.
Оленева, Е.В.
doaj   +1 more source

The use of atypical antipsychotics in the therapy of depressive episodes in patients with bipolar disorder [PDF]

open access: yes, 2021
This literature review addresses the effi cacy and safety of atypical antipsychotics in patients with bipolar depression. Th e results of randomized studies and systematic meta-analyses of recent years were revised in detail.
E. A. Strel’tsov
core   +2 more sources

Metabolic adverse effects of antipsychotics: the state of the problem and management options [PDF]

open access: yes, 2023
Antipsychotic  drugs are widely used for many psychiatric disorders, such as schizophrenia, bipolar affective disorder, delusions and hallucinations  due to neurological  disorders, depression with severe psychotic  symptoms.
A. V. Balashova   +3 more
core   +2 more sources

Possibilities for the use of hydroxychloroquine for pre- and postexposure prophylaxis of SARS-CoV-2 infection among exposed contacts and healthcare personnel [PDF]

open access: yes, 2020
There currently exists no published robust data which would confirm effectiveness and safety of hydroxychloroquine in pre- and postexposure prophylaxis of SARS-CoV-2 infection.
A. V. Krykov   +2 more
core   +2 more sources

Депрессия при шизофрении:патофизиологические механизмы и терапевтические подходы

open access: yesСовременная терапия психических расстройств, 2018
Депрессия – широко распространенный феномен в структуре шизофрении, который связан с более тяжелым течением заболевания, снижениN ем качества жизни и суицидальным поведением.
Рукавишников, Г.В.   +1 more
doaj   +1 more source

Cognitive impairments in schizophrenia and their impact on oxidative stress [PDF]

open access: yes, 2022
The article is devoted to modern concepts of cognitive disorders in schizophrenia. Neurocognitive deficits can be expressed in impaired attention, auditory memory, motor skills, working memory, processing speed and executive function.
A. S. Piatoikina   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy